Branddocs acquires and merges with TrustCloud – becomes the first global digital transactions choreographer
11.4.2023 12:30:00 EEST | Business Wire | Press release
Branddocs Inc, a prominent provider of secure digital transactions and video verification services, has announced today it is acquiring TrustCloud Inc, the world's first choreographing platform for secure digital transactions, in a move that strengthens its commitment to building trust and confidence in the digital economy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230411005217/en/
The Capabilities of the TrustCloud Choreography Platform (Graphic: Business Wire)
The newly merged company will trade as TrustCloud; combining former Branddocs’ large client base and its in-house network of fraud detection experts, AI/ML technologies, multi-orchestration capabilities and the widely acclaimed TrustCloud modular platform to deliver a globally compliant, frictionless and vendor-agnostic user journey. Clients include industry leaders such as JPMorgan Chase, Santander, BBVA, Willis Tower Watson, Direct Line and HDI, as well as government entities, healthcare providers and fast-growing Fintech companies, to name but a few.
“Knowing we can now offer one singular SaaS platform with one API and SLA across all our integrated vendors means our clients can now implement truly global and transformational orchestration solutions for every type of digital transaction – from eSignature to IAM and ID verification to the custody of digital assets in TrustCloud Vault. Our plug and play platform prevents the heartache of vendor lock-in, empowering clients with the freedom to choose any provider with per-transaction pricing. Any existing solution can be seamlessly integrated into TrustCloud’s vendor hub, which means zero interruption to our clients’ infrastructure and services,” states Branddocs’ CEO, Christoph Sauerwein.
As the world’s most certified Qualified Trust Service Provider (QTSP), TrustCloud effectively shields clients' global digital ecosystems, ensuring additional security and compliance at every level of transactional orchestration. Its unique choreographic ability allows for seamless management of high transaction volumes across various geographies while still maintaining an agile and adaptable approach.
“TrustCloud's unwavering commitment to building trust, coupled with cutting-edge technology and simplification of processes, enables businesses and consumers to engage in online transactions with greater ease and security. Due to our humanistic approach, by prioritising user control and visibility across the digital journey, we are seeing conversion rates significantly increase for our clients,” says Saioa Echebarria, CEO of TrustCloud.
About TrustCloud
TrustCloud is a secure digital transaction choreographer (SDTC) providing a range of services, including identity verification, authentication and authorization, encryption, digital signature verification, e-vaulting and e-archiving. These services are designed to protect the confidentiality, integrity, and availability of sensitive information, such as personal and financial data, throughout the entire digital transaction process. TrustCloud is also recognised as the most certified Qualified Trust Service Provider (QTSP) globally with certifications including ISO 27001, 17068, 22301, 27017, 27018, 27701, NIST 800-63 & 800-171, SOC2, HIPAA and eIDAS among others.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230411005217/en/
Contact information
For further information visit Trustcloud.tech. For press enquiries email: press@trustcloud.tech
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom